Bibo Tan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- RNA modifications and cancer 17
- Cancer-related gene regulation 15
- Circular RNAs in diseases 12
- S100 Proteins and Annexins 10
-
- Gastric Cancer Management and Outcomes 23
- Co-authors
- Liqiao Fan (58 shared papers)Qun Zhao (56 shared papers)Yong Li (37 shared papers)Yong Li (11 shared papers)Peigang Yang (16 shared papers)Dong Wang (20 shared papers)Yuan Tian (14 shared papers)Xuefeng Zhao (16 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Tumor Biology (4 papers)Frontiers in Oncology (4 papers)Frontiers in Cell and Developmental Biology (2 papers)Technology in Cancer Research & Treatment (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bibo Tan
101 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 558
- Gastroenterology 71
- Molecular Biology 790
- Oncology 255
- Pulmonary and Respiratory Medicine 290
Countries citing papers authored by Bibo Tan
This map shows the geographic impact of Bibo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bibo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bibo Tan more than expected).
Fields of papers citing papers by Bibo Tan
This network shows the impact of papers produced by Bibo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bibo Tan. The network helps show where Bibo Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bibo Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 104 | |
| 2 | 2013 | 63 | |
| 3 | 2014 | 56 | |
| 4 | 2015 | 54 | |
| 5 | 2020 | 49 | |
| 6 | 2017 | 46 | |
| 7 | 2015 | 43 | |
| 8 | 2015 | 36 | |
| 9 | 2019 | 33 | |
| 10 | 2018 | 29 | |
| 11 | 2014 | 26 | |
| 12 | 2017 | 25 | |
| 13 | 2021 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 2013 | 24 | |
| 16 | 2022 | 24 | |
| 17 | 2016 | 24 | |
| 18 | 2018 | 24 | |
| 19 | 2018 | 23 | |
| 20 | 2018 | 22 |
About Bibo Tan
Bibo Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 103 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (23 papers), RNA modifications and cancer (17 papers), MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (16 papers), Cancer-related gene regulation (15 papers), Circular RNAs in diseases (12 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and S100 Proteins and Annexins (10 papers). The work is most often cited by research in Cancer Research (558 citations), Gastroenterology (71 citations), Molecular Biology (790 citations), Oncology (255 citations) and Pulmonary and Respiratory Medicine (290 citations). Bibo Tan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Liqiao Fan, Qun Zhao, Yong Li, Yong Li, Peigang Yang, Dong Wang, Yuan Tian, Xuefeng Zhao, Zhidong Zhang and Feng Liu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Tumor Biology, Frontiers in Oncology, Frontiers in Cell and Developmental Biology and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.